Clinical Trials Logo

Ischemia clinical trials

View clinical trials related to Ischemia.

Filter by:

NCT ID: NCT00360386 Completed - Ischemia Clinical Trials

ALBION "Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis"

Start date: March 2004
Phase: Phase 2
Study type: Interventional

- To compare the Kinetics of inhibition of platelet aggregation (aggregometry) and platelet activation (flow cytometry) with different loading doses of clopidogrel - To evaluate the effect on various parameters of inflammation and necrosis and the safety of these loading doses

NCT ID: NCT00355992 Terminated - Clinical trials for Ischemic Heart Disease

The Ischemia Modified Albumin In Diagnosing Ischemic New Events

IMAgine
Start date: September 2006
Phase: N/A
Study type: Observational

The purpose of the study is to evaluate the utility of Ischemia Modified Albumin (IMA) for risk stratification in patients presenting with chest discomfort and possible ischemic heart disease, and to evaluate the diagnostic and prognostic implication for IMA for major adverse cardiac events.

NCT ID: NCT00355147 Completed - Ischemic Stroke Clinical Trials

Adapting Tools to Implement Stroke Risk Management to Veterans

TOOLS
Start date: January 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to develop and evaluate the local adaptation of existing stroke prevention tools into practice. A stroke prevention program is a collection of materials including written materials like pamphlets and brochures, videotapes and training guides for stroke survivors and evidence based guidelines for the doctors that provide care for them. Other tools that may be used in a stroke prevention program include devices that help patients monitor medical symptoms at home like home blood pressure machines or blood sugar monitors and messaging devices that allow reporting symptoms from home to a health care provider. We hypothesized Veterans with stroke who receive the Veteran Stroke Prevention Program would engage in better medication compliance and stroke specific quality of life compared to those who did not receive the program.

NCT ID: NCT00346177 Withdrawn - Clinical trials for Cardiovascular Disease

Stem Cell Study for Patients With Heart Failure

Start date: September 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if cell therapy with your own cells (autologous cells) delivered with a catheter to regions of the heart with poor blood flow will be safe and if it will improve your ejection fraction and heart failure symptoms.

NCT ID: NCT00328640 Completed - Ischemic Stroke Clinical Trials

Quality Improvement in Stroke Prevention (QUISP)

Start date: December 2005
Phase: Phase 4
Study type: Interventional

Is a secondary prevention intervention, focused on implementation of standardized pre-printed discharge orders for hospitalists, effective at increasing utilization of the following evidence-based treatments 6 months after discharge for ischemic stroke: 1. Treatment with statins, 2. Control of hypertension, and 3. Anticoagulation in patients with atrial fibrillation.

NCT ID: NCT00326976 Completed - Clinical trials for Myocardial Infarction

Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury

Start date: August 2006
Phase: Phase 2
Study type: Interventional

The purpose of the study is to evaluate whether FX06 is capable of limiting infarct size following balloon catheterization for acute myocardial infarction.

NCT ID: NCT00326690 Withdrawn - Clinical trials for Coronary Artery Disease

Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity

Start date: November 2005
Phase: N/A
Study type: Interventional

The purpose of the present prospective, randomized study is to investigate the clinical effectiveness of standardized left ventricular reconstruction surgery (LVR). In order to standardize the procedure, the operation will be performed with the Blue Egg, manufactured by BioVentrix, a subsidiary of CHF Technologies, Inc.

NCT ID: NCT00321022 Completed - Clinical trials for Transient Ischemic Attack

Transient Ischemic Attack (TIA) Accelerated Diagnostic Protocol

Start date: August 2003
Phase: N/A
Study type: Interventional

The primary objective of this study is to determine if emergency department patients with Transient Ischemic Attack (TIA) that are managed using a TIA "accelerated diagnostic protocol", or "ADP", demonstrate a significant decrease in their index visit length of stay and cost, with comparable diagnostic and 90-day clinical outcomes relative to TIA patients randomized to traditional inpatient care. The secondary objectives are to evaluate the potential role of a TIA risk stratification tool and to determine the time to a diagnostic endpoint in both groups.

NCT ID: NCT00315510 Completed - Ischemia Clinical Trials

Rosuvastatin and Ischemia Reperfusion

Start date: April 2006
Phase: Phase 2
Study type: Interventional

Statins, including rosuvastatin, are drugs that lower plasma cholesterol and prevent atherosclerotic disease. Recent preclinical evidence suggests that statins also increase tissue tolerance to ischemia-reperfusion injury. This is a randomized, double blind, parallel designed study comparing the effect of 1 week treatment with rosuvastatin (20 mg, once a day) with placebo on forearm ischemia-reperfusion injury in healthy male volunteers. Forearm ischemia-reperfusion injury is quantified with Tc-99m-annexin A5 scintigraphy of the hands after a standardized ischemic exercise test. For this purpose, Tc-99m-rh-annexin A5 (400 MBq; < 5 mSv) is injected intravenously upon reperfusion, followed by scintigraphy of both hands with a gamma camera at 1 and 4 hours after injection. Annexin A5 targeting is calculated as the percentage difference in activity (counts/pixel) between the thenar muscles of both hands.

NCT ID: NCT00310622 Unknown status - Myocardial Ischemia Clinical Trials

Assessment of HyperQ Signal for Detecting Ischemia During Dobutamine Stress ECG

Start date: March 2006
Phase: Phase 3
Study type: Interventional

The purpose of the study is to verify the ability of the HyperQ signal to detect Dobutamine induced Ischemia. The gold standard for ischemia will be the results of Angiography if performed, or Echocardiographic imaging, which was performed during the test.